UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
PUT
Canadian Natural Resources
CNQ
$94.6B
| $20.3M | ﹤0.01% |
658,400
+51,000
| +8% | +$1.72M |
|
2302
Recursion Pharmaceuticals
RXRX
$1.69B
| $20.3M | ﹤0.01% |
3,004,645
+2,204,785
| +276% | +$14.8M |
|
2303
Intellia Therapeutics
NTLA
$1.54B
| $20.3M | ﹤0.01% |
1,741,768
+1,463,336
| +526% | +$22.8M |
|
2304
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$495M
| $20.3M | ﹤0.01% |
563,747
-118,191
| -17% | -$4.45M |
|
2305
PUT
Casey's General Stores
CASY
$31.6B
| $20.3M | ﹤0.01% |
51,150
+25
| +0% | +$10.1K |
|
2306
CALL
Ford
F
$56.6B
| $20.3M | ﹤0.01% |
2,045,500
+1,093,800
| +115% | +$11.7M |
|
2307
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $20.2M | ﹤0.01% |
783,725
-38,406
| -5% | -$1.06M |
|
|
BIDD
2308
iShares International Dividend Active ETF
BIDD
$419M
| $20.2M | ﹤0.01% |
+817,542
| New | +$20.7M |
|
2309
Semtech
SMTC
$11.5B
| $20.2M | ﹤0.01% |
325,925
+249,529
| +327% | +$13.2M |
|
2310
CALL
Ross Stores
ROST
$81B
| $20.1M | ﹤0.01% |
133,000
+1,500
| +1% | +$220K |
|
2311
Sibanye-Stillwater
SBSW
$6.99B
| $20.1M | ﹤0.01% |
6,094,013
+1,449,751
| +31% | +$6.1M |
|
2312
Dime Commercial Bancshares
DCOM
$1.83B
| $20.1M | ﹤0.01% |
654,072
+608,942
| +1,349% | +$19.6M |
|
2313
AAR Corp
AIR
$5.9B
| $20.1M | ﹤0.01% |
327,501
+304,523
| +1,325% | +$19.5M |
|
2314
Sotera Health
SHC
$5.12B
| $20.1M | ﹤0.01% |
1,466,873
+1,232,373
| +526% | +$17.9M |
|
2315
John Hancock Multifactor Small Cap ETF
JHSC
$745M
| $20.1M | ﹤0.01% |
504,786
-4,303
| -0.8% | -$177K |
|
2316
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $20.1M | ﹤0.01% |
767,029
+87,138
| +13% | +$2.33M |
|
2317
PUT
Nucor
NUE
$62.4B
| $20M | ﹤0.01% |
171,700
| – | – |
|
2318
Evolent Health
EVH
$345M
| $20M | ﹤0.01% |
1,780,967
+1,639,342
| +1,158% | +$28.8M |
|
2319
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
| $20M | ﹤0.01% |
1,852,977
+26,574
| +1% | +$300K |
|
2320
Dolby
DLB
$5.68B
| $20M | ﹤0.01% |
256,445
+36,917
| +17% | +$2.81M |
|
|
2321
PUT
Ford
F
$56.6B
| $20M | ﹤0.01% |
2,021,600
+1,319,400
| +188% | +$14.1M |
|
2322
Ally Financial
ALLY
$13.6B
| $20M | ﹤0.01% |
555,780
+106,413
| +24% | +$3.86M |
|
2323
Iovance Biotherapeutics
IOVA
$1.97B
| $20M | ﹤0.01% |
2,704,469
+2,082,340
| +335% | +$19.3M |
|
2324
State Street SPDR Dow Jones REIT ETF
RWR
$1.98B
| $19.9M | ﹤0.01% |
201,590
+5,858
| +3% | +$610K |
|
2325
Healthcare Realty
HR
$7.01B
| $19.9M | ﹤0.01% |
1,173,393
+783,577
| +201% | +$13.8M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.